[HTML][HTML] Current research on zinc oxide nanoparticles: synthesis, characterization, and biomedical applications

AK Mandal, S Katuwal, F Tettey, A Gupta, S Bhattarai… - Nanomaterials, 2022 - mdpi.com
Zinc oxide nanoparticles (ZnO-NPs) have piqued the curiosity of researchers all over the
world due to their extensive biological activity. They are less toxic and biodegradable with …

Omics approaches for the assessment of biological responses to nanoparticles

Y Abdelkader, L Perez-Davalos, R LeDuc… - Advanced Drug Delivery …, 2023 - Elsevier
Nanotechnology has enabled the development of innovative therapeutics, diagnostics, and
drug delivery systems. Nanoparticles (NPs) can influence gene expression, protein …

[HTML][HTML] Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

S Mickymaray, FA Alfaiz, A Paramasivam… - Saudi journal of …, 2021 - Elsevier
Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma
incidences are more than 10% within the population. Most of the patients with osteosarcoma …

[HTML][HTML] Green synthesis of zinc oxide nanoparticles: eco-friendly advancements for biomedical marvels

J Nandhini, E Karthikeyan, S Rajeshkumar - Resources Chemicals and …, 2024 - Elsevier
This article explores an in-depth analysis of eco-friendly green synthesis methods to
manufacture zinc oxide nanoparticles (ZnO NPs). Although chemical and/or physical …

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia

SA Alsagaby, D Iqbal, I Ahmad, H Patel, SA Mir… - Scientific reports, 2022 - nature.com
Chronic lymphocytic leukemia (CLL) is an incurable malignancy of B-cells. In this study,
bioinformatics analyses were conducted to identify possible pathogenic roles of CK2α …

Anticancer effect of zinc oxide nanoparticles prepared by varying entry time of ion carriers against A431 skin cancer cells in vitro

AY Aljohar, G Muteeb, Q Zia, S Siddiqui, M Aatif… - Frontiers in …, 2022 - frontiersin.org
Although, zinc oxide nanoparticles (ZRTs) as an anti-cancer agent have been the subject of
numerous studies, none of the reports has investigated the impact of the reaction entry time …

[HTML][HTML] Targeting engineered nanoparticles for breast cancer therapy

K Ganesan, Y Wang, F Gao, Q Liu, C Zhang, P Li… - Pharmaceutics, 2021 - mdpi.com
Breast cancer (BC) is the second most common cancer in women globally after lung cancer.
Presently, the most important approach for BC treatment consists of surgery, followed by …

[HTML][HTML] Analysis of nanotoxicity with integrated omics and mechanobiology

TH Shin, S Nithiyanandam, DY Lee, DH Kwon… - Nanomaterials, 2021 - mdpi.com
Nanoparticles (NPs) in biomedical applications have benefits owing to their small size.
However, their intricate and sensitive nature makes an evaluation of the adverse effects of …

A New Look at the Effects of Engineered ZnO and TiO2 Nanoparticles: Evidence from Transcriptomics Studies

S Wang, H Alenius, H El-Nezami, P Karisola - Nanomaterials, 2022 - mdpi.com
Titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles (NPs) have attracted a great
deal of attention due to their excellent electrical, optical, whitening, UV-adsorbing and …

Metal nanoparticles: biomedical applications and their molecular mechanisms of toxicity

A Malik, JM Khan, AS Alhomida, MS Ola, MA Alshehri… - Chemical Papers, 2022 - Springer
Novel breakthroughs and innovative applications of nanotechnology have revolutionized the
industrial innovations of the twenty-first century. The exciting potential of nanomaterials …